Estrogen action on bone marrow osteoclast lineage cells of postmenopausal women in vivo

Osteoporosis International

Volumn 20, Issue 5, 2009, Pages 761-769

  Clowes, J A ^a   Eghbali Fatourechi, G Z ^a   McCready, L ^a   Oursler, M J ^a   Khosla, S ^a   Riggs, B L ^a  

^a Mayo Clinic College of Medicine   (United States)

Author keywords

Bone resorption; Bone resorption markers; Cytokines; Estrogen; Osteoclast differentiation; Osteoclast precursors; Osteoclasts; Postmenopausal women

Indexed keywords

ANTIBODY; CALCITONIN RECEPTOR; CARBOXY TERMINAL TELOPEPTIDE; ESTRADIOL; FLUORESCENT DYE; MEMBRANE RECEPTOR; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2;

ADULT; AGED; ARTICLE; BONE MARROW BIOPSY; BONE MARROW CELL; CELL DIFFERENTIATION; CELL LINEAGE; CELL MATURATION; CLINICAL TRIAL; CONCENTRATION (PARAMETERS); CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG MECHANISM; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IN VIVO STUDY; MONONUCLEAR CELL; OSTEOCLAST; OSTEOLYSIS; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; BONE MARROW CELLS; BONE RESORPTION; CELL DIFFERENTIATION; CELL LINEAGE; CYTOKINES; ESTRADIOL; ESTROGENS; FEMALE; FLOW CYTOMETRY; HUMANS; MIDDLE AGED; OSTEOCLASTS; POSTMENOPAUSE; RECEPTORS, CALCITONIN;

EID: 63949087888     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-008-0731-y     Document Type: Article

References (27)

1. SR Cummings LJ Melton 2002 Epidemiology and outcomes of osteoporotic fractures Lancet 359 1761 1767
2. BL Riggs S Khosla LJ Melton 2002 Sex steroids and the construction and conservation of the adult skeleton Endocr Rev 23 279 302
3. EF Eriksen DS Colvard NJ Berg ML Graham KG Mann TC Spelsberg BL Riggs 1988 Evidence of estrogen receptors in normal human osteoblast-like cells Science 241 84 86
4. BS Komm CM Terpening DJ Benz KA Graeme BW O'Malley MR Haussler 1988 Estrogen binding receptor mRNA, and biologic response in osteoblast-like osteosarcoma cells Science 241 81 84
5. JA Clowes BL Riggs S Khosla 2005 The role of the immune system in the pathophysiology of osteoporosis Immunol Rev 208 207 227
6. MN Weitzmann R Pacifici 2006 Estrogen deficiency and bone loss: an inflammatory tale J Clin Invest 116 1186 1194
7. MJ Oursler P Osdoby J Pyfferoen BL Riggs TC Spelsberg 1991 Avian osteoclasts as estrogen target cells Proc Natl Acad Sci U S A 88 6613 6617
8. NK Shevde AC Bendixen KM Dienger JW Pike 2000 Estrogens suppress RANK ligand-induced osteoclast differentiation via a stromal cell independent mechanism involving c-Jun repression Proc Natl Acad Sci U S A 97 7829 7834
9. S Srivastava G Toraldo MN Weitzmann S Cenci FP Ross R Pacifici 2001 Estrogen decreases osteoclast formation by down-regulating receptor activator of NF-kB ligand (RANKL)-induced JNK activation J Biol Chem 276 8836 8840
10. T Nakamura Y Imai T Matsumoto S Sato K Takeuchi K Igarashi Y Harada Y Azuma A Krust Y Yamamoto H Nishina S Takeda H Takayanagi D Metzger J Kanno K Takaoka TJ Martin P Chambon S Kato 2007 Estrogen prevents bone loss via estrogen receptor alpha and induction of fas ligand in osteoclasts Cell 130 811 823
11. G Eghbali-Fatourechi S Khosla A Sanyal WJ Boyle DL Lacey BL Riggs 2003 Role of RANK ligand in mediating increased bone resorption in early postmenopausal women J Clin Invest 111 1221 1230
12. P Taxel H Kaneko S-K Lee HL Aguila LG Raisz JA Lorenzo 2008 Estradiol rapidly inhibits osteoclastogenesis and RANKL expression in bone marrow cultures in postmenopausal women: a pilot study Osteoporos Int 19 193 199
13. MG Sorensen K Henriksen MH Dziegiel LB Tanko MA Karsdal 2006 Estrogen directly attenuates human osteoclastogenesis, but has no effect on resorption by mature osteoclasts DNA Cell Biol 25 475 483
14. K Henriksen LB Tanko P Qvist PD Delmas C Christiansen MA Karsdal 2007 Assessment of osteoclast number and function: application in the development of new and improved treatment modalities for bone diseases Osteoporos Int 18 681 685
15. A Mochizuki M Takami T Kawawa R Suzumoto T Sasaki A Shiba H Tsukasaki B Zhao R Yasuhara T Suzawa Y Miyamoto Y Choi R Kamijo 2006 Identification and characterization of the precursors committed to osteoclasts induced by TNF-related activation-induced cytokine-receptor activator of NF-kappa B ligand J Immunol 177 4360 4368
16. MJ Oursler L Pederson L Fitzpatrick BL Riggs 1994 Human giant cell tumors of the bone (osteoclastomas) are estrogen target cells Proc Natl Acad Sci U S A 91 5227 5231
17. SL Teitelbaum 2000 Bone resorption by osteoclasts Science 289 1504 1508
18. R Baron 2004 Arming the osteoclast Nat Med 10 458 460
19. M Asagiri H Takayanagi 2007 The molecular understanding of osteoclast differentiation Bone 40 251 264
20. LC Hofbauer S Khosla CR Dunstan DL Lacey WJ Boyle BL Riggs 2000 The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption J Bone Miner Res 15 2 12
21. T Koga M Inui K Inoue S Kim A Suematsu E Kobayashi T Iwata H Ohnishi T Matozaki T Kodama T Taniguchi H Takayanagi T Takai 2004 Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis Nature 428 758 763
22. K Kobayashi N Takahashi E Jimi N Udagawa M Takami S Kotake N Nakagawa M Kinosaki K Yamaguchi N Shima H Yasuda T Morinaga K Higashio TJ Martin T Suda 2000 Tumor necrosis factor a stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction J Exp Med 191 275 285
23. J Lam S Takeshita JE Barker O Kanagawa FP Ross SL Teitelbaum 2000 TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand J Clin Invest 106 1481 1488
24. Y-H Zhang A Heulsmann MM Tondravi A Mukherjee Y Abu-Amer 2001 Tumor necrosis factor-alpha (TNF) stimulates RANKL-induced osteoclastogenesis via coupling of TNF type 1 receptor and RANK signaling pathways J Biol Chem 276 563 568
25. E Sariban K Imamura M Sherman V Rothwell P Pantazis D Kufe 1989 Downregulation of c-Fms gene expression in human monocytes treated with phorbol esters and colony-stimulating factor 1 Blood 74 129 129
26. S Cenci MN Weitzmann MA Gentile MC Aisa R Pacifici 2000 M-CSF neutralization and Egr-1 deficiency prevent ovariectomy-induced bone loss J Clin Invest 105 1279 1287
27. Y Abu-Amer J Erdmann L Alexopoulou G Kollias FP Ross SL Teitelbaum 2000 Tumor necrosis factor receptors types 1 and 2 differentially regulate osteoclastogenesis J Biol Chem 275 27307 27310